Arecor Proprietary Pipeline

Using our Arestat™ technology platform, we are developing enhanced medicines for the treatment of diabetes and other chronic conditions

Tetris Pharma Portfolio

Our specialty pharmaceutical experts in registering, marketing, sales and the distribution of commercial-stage speciality hospital products across the UK and Europe

Our Partners

We partner with leading pharmaceutical and biotechnology companies through technology partnerships to enhance their proprietary products across a range of indications and stages of development

Latest News and Events

  • 7th September 2023

    ARECOR ANNOUNCES POSITIVE PRE-IND MEETING WITH FDA FOR NOVEL READY-TO-USE MEDICINE AT307 LICENSED TO HIKMA

  • 4th September 2023

    TETRIS PHARMA ANNOUNCES COMMERCIALISATION AGREEMENT WITH GOODLIFE

  • 17th August 2023

    ARECOR TO COLLABORATE WITH TOP 10 GLOBAL PHARMACEUTICAL COMPANY